GSK Investigational Site is a clinical research site located in Denver, Colorado, United States 80220.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 180 clinical trials with 11 currently active.
Therapeutic areas: Infection, Human Immunodeficiency Virus, Lung Cancer, Non-Small Cell, Non-Small-Cell Lung Cancer.
Sponsors: ViiV Healthcare, GlaxoSmithKline, XenoPort, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Colorado · View every site in Denver
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 180 clinical trials on record, with 11 currently active. Their work covers Infection, Human Immunodeficiency Virus, Lung Cancer, Non-Small Cell, Non-Small-Cell Lung Cancer.
GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.